Protagonist Therapeutics
PTGX
PTGX
136 hedge funds and large institutions have $1.22B invested in Protagonist Therapeutics in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
–
Holders Change %
0%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
33
Increased
44
Reduced
44
Closed
32
Calls
$42.3M
Puts
$13.2M
Net Calls
+$29.1M
Net Calls Change
+$21.3M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$86.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$58.8M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$39.1M |
| 4 |
RI
RTW Investments
New York
|
$106M |
| 5 |
PA
Perceptive Advisors
New York
|
$22.2M |
